全文获取类型
收费全文 | 2537篇 |
免费 | 155篇 |
国内免费 | 18篇 |
专业分类
耳鼻咽喉 | 35篇 |
儿科学 | 68篇 |
妇产科学 | 39篇 |
基础医学 | 282篇 |
口腔科学 | 91篇 |
临床医学 | 254篇 |
内科学 | 619篇 |
皮肤病学 | 78篇 |
神经病学 | 180篇 |
特种医学 | 127篇 |
外科学 | 502篇 |
综合类 | 14篇 |
预防医学 | 80篇 |
眼科学 | 36篇 |
药学 | 132篇 |
中国医学 | 2篇 |
肿瘤学 | 171篇 |
出版年
2024年 | 1篇 |
2023年 | 7篇 |
2022年 | 24篇 |
2021年 | 53篇 |
2020年 | 31篇 |
2019年 | 48篇 |
2018年 | 61篇 |
2017年 | 48篇 |
2016年 | 65篇 |
2015年 | 57篇 |
2014年 | 124篇 |
2013年 | 115篇 |
2012年 | 194篇 |
2011年 | 220篇 |
2010年 | 140篇 |
2009年 | 135篇 |
2008年 | 215篇 |
2007年 | 229篇 |
2006年 | 200篇 |
2005年 | 184篇 |
2004年 | 144篇 |
2003年 | 136篇 |
2002年 | 142篇 |
2001年 | 31篇 |
2000年 | 18篇 |
1999年 | 18篇 |
1998年 | 26篇 |
1997年 | 7篇 |
1996年 | 6篇 |
1995年 | 5篇 |
1994年 | 5篇 |
1992年 | 1篇 |
1991年 | 2篇 |
1990年 | 3篇 |
1989年 | 2篇 |
1988年 | 1篇 |
1987年 | 2篇 |
1985年 | 2篇 |
1984年 | 2篇 |
1983年 | 1篇 |
1980年 | 2篇 |
1971年 | 2篇 |
1969年 | 1篇 |
排序方式: 共有2710条查询结果,搜索用时 15 毫秒
991.
992.
993.
Schefold JC 《Critical care (London, England)》2011,15(2):136-2
Sepsis is associated with failure of multiple organs, including failure of the immune system. The resulting 'sepsis-associated
immunosuppression' resembles a state of immunological anergy that is characterized by repeated 'infectious hits', prolonged
multiple-organ failure, and death. As a consequence, adjunctive treatment approaches using measures of immunostimulation with
colony-stimulating factors (CSFs) were tested in animal experiments and clinical trials. Herein, data from randomized clinical
trials will be discussed in the context of a recently published meta-analysis investigating the effects of granulocyte- and
granulocyte-macrophage colony-stimulating factor therapy in patients with severe sepsis and septic shock. 相似文献
994.
Nicole M. Davis Melissa Sokolosky Kristin Stadelman Stephen L. Abrams Massimo Libra Saverio Candido Ferdinando Nicoletti Jerry Polesel Roberta Maestro Antonino D’Assoro Lyudmyla Drobot Dariusz Rakus Agnieszka Gizak Piotr Laidler Joanna Dulińska-Litewka Joerg Basecke Sanja Mijatovic Danijela Maksimovic-Ivanic Giuseppe Montalto Melchiorre Cervello Timothy L. Fitzgerald Zoya N. Demidenko Alberto M. Martelli Lucio Cocco Linda S. Steelman James A. McCubrey 《Oncotarget》2014,5(13):4603-4650
The EGFR/PI3K/PTEN/Akt/mTORC1/GSK-3 pathway plays prominent roles in malignant transformation, prevention of apoptosis, drug resistance and metastasis. The expression of this pathway is frequently altered in breast cancer due to mutations at or aberrant expression of: HER2, ERalpha, BRCA1, BRCA2, EGFR1, PIK3CA, PTEN, TP53, RB as well as other oncogenes and tumor suppressor genes. In some breast cancer cases, mutations at certain components of this pathway (e.g., PIK3CA) are associated with a better prognosis than breast cancers lacking these mutations. The expression of this pathway and upstream HER2 has been associated with breast cancer initiating cells (CICs) and in some cases resistance to treatment. The anti-diabetes drug metformin can suppress the growth of breast CICs and herceptin-resistant HER2+ cells. This review will discuss the importance of the EGFR/PI3K/PTEN/Akt/mTORC1/GSK-3 pathway primarily in breast cancer but will also include relevant examples from other cancer types. The targeting of this pathway will be discussed as well as clinical trials with novel small molecule inhibitors. The targeting of the hormone receptor, HER2 and EGFR1 in breast cancer will be reviewed in association with suppression of the EGFR/PI3K/PTEN/Akt/mTORC1/GSK-3 pathway. 相似文献
995.
996.
997.
998.
Benninger E Laschke MW Cardell M Holstein JH Lustenberger T Keel M Trentz O Menger MD Meier C 《Shock (Augusta, Ga.)》2012,38(4):420-428
ABSTRACT: The aim of this study was to evaluate microdialysis of the rectus abdominis muscle (RAM) for early detection of subclinical organ dysfunction in a porcine model of critical intra-abdominal hypertension (IAH). Microdialysis catheters for analyses of lactate, pyruvate, and glycerol levels were placed in cervical muscles (control), gastric and jejunal wall, liver, kidney, and RAM of 30 anesthetized mechanically ventilated pigs. Catheters for venous lactate and interleukin 6 samples were placed in the jugular, portal, and femoral vein. Intra-abdominal pressure (IAP) was increased to 20 mmHg (IAH20 group, n = 10) and 30 mmHg (IAH30, n = 10) for 6 h by controlled CO2 insufflation, whereas sham animals (n = 10) exhibited a physiological IAP. In contrast to 20 mmHg, an IAH of 30 mmHg induced pathophysiological alterations consistent with an abdominal compartment syndrome. Microdialysis showed significant increase in the lactate/pyruvate ratio in the RAM of the IAH20 group after 6 h. In the IAH30 group, the strongest increase in lactate/pyruvate ratio was detected in the RAM and less pronounced in the liver and gastric wall. Glycerol increased in the RAM only. After 6 h, there was a significant increase in venous interleukin 6 of the IAH30 group compared with baseline. Venous lactate was increased compared with baseline and shams in the femoral vein of the IAH30 group only. Intra-abdominal pressure-induced ischemic metabolic changes are detected more rapidly and pronounced by microdialysis of the RAM when compared with intra-abdominal organs. Thus, the RAM represents an important and easily accessible site for the early detection of subclinical organ dysfunction during critical IAH. 相似文献
999.
Hawe A Wiggenhorn M van de Weert M Garbe JH Mahler HC Jiskoot W 《Journal of pharmaceutical sciences》2012,101(3):895-913
The scope of this paper is to review approaches used for forced degradation (synonym, stress testing) of therapeutic proteins. Forced degradation studies play a central role in the development of therapeutic proteins, for example, for candidate selection, molecule characterization, formulation development, assay development, and comparability studies. Typical stress methods are addressed within this review, such as exposure to elevated temperatures, freeze-thawing, mechanical stress, oxidation, light, as well as various materials and devices used in the clinics during final administration. Stability testing is briefly described as far as relevant to the discussion of forced degradation studies. Whereas stability-testing requirements are defined in regulatory guidelines, standard procedures for forced degradation of therapeutic proteins are largely unavailable, except for photostability. Possible selection criteria to identify appropriate stress conditions and recommendations for setting up forced degradation studies for the different phases of development of therapeutic proteins are presented. 相似文献
1000.
Rottenkolber D Schmiedl S Rottenkolber M Thuermann PA Hasford J 《Basic & clinical pharmacology & toxicology》2012,111(4):240-247
Therapy for adverse drug reactions (ADRs) often results in the application of blood components. This study aims to assess the demand for blood components and the resulting economic burden (hospital perspective) in German hospitals induced by ADRs leading to admissions to departments of internal medicine. In this prospective study, ADRs leading to hospitalization were surveyed in four regional pharmacovigilance centres in Germany during the years 2000–2007. ADRs assessed as ‘possible’, ‘likely’ or ‘very likely’ were included. Market prices for blood components and hospitalization data were determined by desktop research. A probabilistic sensitivity analysis was performed. A total of 6099 patients were admitted to internal medicine departments because of an outpatient ADR of whom 1165 patients (19.1%; mean age, 73.0 ± 13.0 years) required treatment with blood components owing to major bleeding events. Overall consumption was 4185 erythrocyte concentrates (EC), 426 fresh frozen plasma (FFP) and 48 thrombocyte (TC) units. On the basis of statistical hospital data, we estimated a nationwide demand of approximately 132,020 EC, 13,440 FFP and 1515 TC units, resulting in total costs of €12.66 million per year for all German hospitals. Some 19.2% of all ADR cases were assessed as preventable. Theoretically, a nationwide decreased demand for blood components and a savings potential of €2.43 million per year could be achieved by preventing ADRs in Germany. Blood components are used in one‐fifth (mainly gastrointestinal bleeding) of all ADRs, leading to hospitalizations in internal medicine departments. Both blood demand and hospital procurement costs can be significantly lowered by preventing ADRs. 相似文献